About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNEARLY Phase 1NCT05998174

Faecal Microbiota Transplantation for Microscopic Colitis

A pilot study investigating if orally administrated faecal microbiota transplantation capsules have the potential to treat active microscopic colitis.

Lead sponsor: Hvidovre University Hospital•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hvidovre University Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of microscopic colitis
•Date of diagnosis/histological confirmation \< 12 months
•Active disease according to Hjortswang's criteria

Exclusion Criteria

•Diagnosed with ulcerative colitis or Crohn's disease
•Diagnosed with celiac disease
•Active gastrointestinal infection
•Previous bowel resection of bowel (except appendectomy)
•Previous cholecystectomy
•Treatment with systemic steroid within 4 weeks, including budesonide
•Antibiotics 3 months prior
•Severe immunodeficiency,
•Pregnancy, planned pregnancy and breastfeeding
•Treatment with constipants such as psyllium, loperamide, bile binders, opium drops or codeine up to 2 weeks before inclusion and during participation

Related studies

Enrolling By Invitation

Enabling Microbiomics- Driven Personalized Nutrition

NCT06657001 · Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and more

Active Not Recruiting

Chronic Diarrhea Owing to Underlying Microscopic Colitis

NCT06530836 · Chronic Diarrhea, Microscopic Colitis

Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre

NCT05058131 · Microscopic Colitis

COMPLETEDPhase 3

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

NCT02142634 · Incomplete Microscopic Colitis

Faecal Microbiota Transplantation in Patients With Microscopic Colitis

NCT03275467 · Microscopic Colitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 18, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseEARLY_PHASE1

Enrollment20

Start dateSep 2023

Last updatedAug 18, 2023

Condition

Microscopic Colitis

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions